Markets:

Overview

News

Currencies

International

Treasuries

Dr. Reddy's Laboratories Ltd Common Stock (NY:RDY)

13.68 -0.10 (-0.73%)

Streaming Delayed Price Updated: 11:57 AM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dr. Reddy's Laboratories Ltd Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Happy New Year - Sunday Edition ↗

January 02, 2022

Starting a new year - we look at tech, pharma and mining stocks and their goings-on.

Via Talk Markets

Market Trend: Erratic And Unreliable ↗

December 29, 2021

Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.

Via Talk Markets

A Bit Of Good News ↗

December 22, 2021

US growth figures for Q3 were up from forecasts of 2.1% at 2.3% but well down from the prior quarter level of 6.7%.

Via Talk Markets

Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market

December 09, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market

December 09, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia

December 08, 2021

From Prestige BioPharma Ltd.

Via Business Wire

5 Reasons Why Sensex Crashed, Tarsons Products' Lukewarm Debut, And Buzzing Stocks Today ↗

November 29, 2021

Indian share markets, which ended deep in the red on Friday, are headed for a gap-up opening today following the trend on SGX Nifty.

Via Talk Markets

Tuesday Market Overview ↗

November 16, 2021

While gold gained modestly again today, cryptocurrencies fell hard.

Via Talk Markets

Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters ↗

November 16, 2021

Dr. Reddy's Laboratories Ltd (NYSE: RDY) said it was open to making Pfizer Inc's (NYSE: PFE) COVID-19 antiviral pill, Reuters reported. The new drugs can...

Via Benzinga

Dr. Reddy's Laboratories Announces the Launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market

October 29, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Wednesday Market Coverage ↗

October 20, 2021

Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal.

Via Talk Markets

Bitcoin Futures Arrive ↗

October 19, 2021

Today you can finally hold Bitcoins via an exchange-traded fund.

Via Talk Markets

The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio ↗

October 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Entasis Announces Positive Data For Late-Stage Study Of SUL-DUR In...

Via Benzinga

Dr. Reddy's Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)

October 19, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market

October 15, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters ↗

October 08, 2021

According to a source with the Drug Controller General of India, Merck & Co Inc's (NYSE: MRK) antiviral drug molnupiravir has not shown "significant...

Via Benzinga

A Bit Of A Recovery ↗

September 29, 2021

While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.

Via Talk Markets

Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential ↗

September 10, 2021

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)

Via Benzinga

Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma ↗

September 07, 2021

Citius Pharmaceuticals Inc has agreed to acquire anti-cancer agent E7777 from Dr. Reddy's Laboratories Ltd (NYSE: RDY). E7777 is an engineered IL-2-...

Via Benzinga

Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)

September 04, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Mu - The Newest Worry ↗

September 03, 2021

Today London and New York fell on the huge drop in new employment levels in August.

Via Talk Markets

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market

September 02, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Dr. Reddy's Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market

August 31, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Delta Outbreak ↗

August 04, 2021

The US market was droopy because of poor private sector jobless numbers.

Via Talk Markets

BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Range ↗

August 04, 2021

BioDelivery Sciences International Inc (NASDAQ: BDSI) has reported Q2 sales of $41.4 million, + 13.3% Y/Y, missing the consensus of $42.4 million. Sales growth...

Via Benzinga

Dr. Reddy’s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB (celecoxib oral solution) 25 mg/mL

August 04, 2021

From Dr. Reddy’s Laboratories Limited

Via Business Wire

Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market

August 03, 2021

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

DrReddy's Laboratories Ltd (RDY) Q1 2022 Earnings Call Transcript ↗

July 29, 2021

RDY earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Full News Day ↗

July 28, 2021

The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.

Via Talk Markets

Topics Energy

Banned Merger ↗

July 27, 2021

Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.